OUTLINE YOUR CONTOUR
Master your lower face treatments with an efficient and safe approach adapted to men and women
The shape of the jawline plays a major role in an individual’s appearance defining a feminine or masculine look.1
A lower face treatment with HA dermal fillers has to be tailored according to the specific morphotype (e.g. gender, ethnicity…) to ensure balance & facial harmony.2,3
Due to the anatomical differences of the chin and jawline, it is key to choose techniques and products adapted to each region’s specificities.
TEOXANE’s complementary RHA® 4 & ULTRA DEEP hyaluronic acid volumizers balance soft volume enhancement and deep structural support allowing you to offer your patient natural-looking contour specifically tailored to them . 4,5
PROJECTION & DEFINITION
ULTRA DEEP*
Firm and static volumizer gel designed to provide deep structural support
TOP BENEFITS CLAIMED BY HEALTH CARE PROFESSIONALS4:
•A good projection with a low quantity of gel
•Chisel angles and jawline
SOFT CONTOURING
RHA® 4*
Moldable and resilient volumizer gel designed to provide soft volume enhancement.
TOP BENEFITS CLAIMED BY HEALTH CARE PROFESSIONALS5:
•Soft and dynamic volume enhancement
•Natural-looking results
MASTER AND UPSKILL YOUR MEDICAL APPROACH
Lower face hyaluronic acid treatments, an increasing demand of more than 50% over the last 5 years is estimated by 74% of HCPs 6
• Discover more clinical cases
Lower face Case Book and its injection videos
• Learn more about safety
TEOXANE risk assessment & injection techniques brochure
• Be trained
NATURAL-LOOKING
OUTCOMES
With a precise placement of adapted hyaluronic acid gels in the angle of the jaw, the chin or the jawline you can frame your patient’s best features and ensure balance & facial harmony.
RHA® SERUM
HIGH HYDRATION & SKIN PLUMPING EFFECT
3% OF RHA® - RESILIENT HYALURONIC ACID®
RHA® Serum is the ideal complement to your procedures.
Revive and protect your skin with crosslinked resilient hyaluronic acid and antioxydants.
HIGH PATIENT SATISFACTION 7
After 14 days, the skin is:
• More HYDRATED 97%
• SMOOTHER 91%
• BRIGHTER 94%
Our recommended routine to maintain results after an aesthetic procedure includes RHA® Micellar Solution (CLEANSE) followed by Deep Repair Balm (SOOTHE) and RHA® Serum (STRENGTHEN & DEEPLY HYDRATE).
References
*RHA ® 4 = TEOSYAL RHA ® 4, ULTRA DEEP = TEOSYAL ® PURESENSE ULTRA DEEP
TEOSYAL RHA ® 4 and TEOSYAL ® PureSense ULTRA DEEP are trademarks of the firm TEOXANE SA. These products are gels that contain hyaluronic acid, and 0.3% by weight of lidocaine hydrochloride (local anesthetic can induce a positive reaction to anti-doping tests). In the case of known hypersensitivity to lidocaine and/or amide local anaesthetic agents, we recommend not to use lidocaine-containing products and to refer to products without lidocaine. TEOSYAL® PureSense ULTRA DEEP exists also without lidocaine: TEOSYAL ® ULTRA DEEP. TEOSYAL RHA® 4 and TEOSYAL® PureSense ULTRA DEEP are class III medical devices and are regulated health product bearing the CE marking (CE2797) under this regulation. For professional use only. Please refer to the Instructions For Use. The product availability depends on registration, please contact your local distributor. Please inform the manufacturer TEOXANE of any side effect or any complaint as soon as possible by sending an email to the following address: medical@teoxane.com.
- Braz A, Eduardo CCP. Reshaping the Lower Face Using Injectable Fillers. Indian J Plast Surg. 2020;53(2):207-218.
- Yutskovskaya YA et al. Contouring of Lower Face and Chin in Consideration of Facial Morphotypes and Shapes- Is it a More Accurate Approach? Madridge J Dermatol Res 2017. 2:1 26-31.
- A. Braz, et al. Lower Face: Clinical Anatomy and Regional Approaches with Injectable Fillers. Plastic and Reconstructive Surgery November Supplement 2015. Volume 136, Number 5S
- TEOSYAL RHA ® 4 - INSTRUCTION FOR USE.
- TEOSYAL ® PURESENSE ULTRA DEEP - INSTRUCTIONS FOR USE
- TEOXANE Internal Lower face Survey 2021 ITALY - 100 Healthcare professionals.
- Self-assessment carried out on 31 volunteers by an independent laboratory during 28 days.
